EUVIMEDEUVIMED entdecken
Crossref

Investigating Therapeutic Potential of Beta‐Glucan on Experimental Toxoplasmosis in Immunocompetent and Immunocompromised Mice: In Silico and in Vivo Studies

Asmaa A Aboul-Fotouh, Faten A Elfeky, Nahed R Omar, Tarek Aboushousha, Eman S El-Wakil iD

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202500370 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Asmaa A Aboul-Fotouh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Zoology Department, Faculty of Science for Girls, Al-Azhar University, Cairo, Egypt. Hauptthemen laut MEDLINE: beta-Glucans, Toxoplasmosis, Antiprotozoal Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is a need to find efficient treatment for toxoplasmosis, a global disease with a public health concern, as the used therapeutics have limited effectiveness. Beta‐glucan (β‐glucan), a natural polysaccharide, has anti‐inflammatory, immunomodulatory, and anti‐infective activities against bacteria, viruses, and parasites. We aimed to investigate the therapeutic efficacy of β‐glucan on toxoplasmosis using an in silico study and an in vivo mice model. The β‐glucan drug‐likeness characteristics were evaluated by molecular docking simulations, Lipinski's RO5 filter analysis, and the computational quantitative structural‐activity relationships/absorption, distribution, metabolism, excretion, and toxicity predictive characteristics compared to spiramycin, an anti‐toxoplasmosis drug. Sixty albino mice were divided into two divisions, immunocompetent and immunosuppressed. Each division contained five groups; healthy, diseased, spiramycin‐treated, β‐glucan‐treated, and both β‐glucan and spiramycin‐treated groups. Parasitological, histopathological examinations, and immunological analysis were detected. β‐glucan docked complexes demonstrated H‐bonding and hydrophobic interactions towards their promising anti‐toxoplasmosis targets compared to the spiramycin. The treated mice revealed a statistically significant reduction ( p < 0.001) in the parasite burden. Regarding immunocompetent and immunosuppressed division, the group that was treated with both β‐glucan and spiramycin, demonstrated the greatest outcomes, with 71% and 66% efficacy, respectively. It is concluded that β‐glucan shows promising potential as an anti‐toxoplasmosis candidate by potentiating the spiramycin effect and modulating the immunological response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-GlucansToxoplasmosisAntiprotozoal AgentsAnimalsMiceMolecular Docking SimulationImmunocompromised HostToxoplasmaDisease Models, AnimalStructure-Activity RelationshipImmunocompetenceFemale

Stichwörter der Autor:innen

T. gondii putative ribose‐5‐phosphate isomeraseantiprotozoal agentsdrug discoverytoxoplasmosisβ‐glucans

Substanzen

beta-GlucansAntiprotozoal Agents

Autor:innen und Institutionen

  • Zoology Department, Faculty of Science for Girls, Al-Azhar University, Cairo, Egypt.
  • Department of Pathology, Theodor Bilharz Research Institute, Giza, Egypt.
  • Department of Parasitology, Theodor Bilharz Research Institute, Giza, Egypt.

ORCID-Profile: Eman S El-Wakil

Zitieren

APA

Aboul-Fotouh, A. A., Elfeky, F. A., Omar, N. R., Aboushousha, T., & El-Wakil, E. S. (2025). Investigating Therapeutic Potential of Beta‐Glucan on Experimental Toxoplasmosis in Immunocompetent and Immunocompromised Mice: In Silico and in Vivo Studies. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202500370

Vancouver

Aboul-Fotouh AA, Elfeky FA, Omar NR, Aboushousha T, El-Wakil ES. Investigating Therapeutic Potential of Beta‐Glucan on Experimental Toxoplasmosis in Immunocompetent and Immunocompromised Mice: In Silico and in Vivo Studies. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202500370

BibTeX
@article{AboulFotouh2025,
  author = {Aboul-Fotouh, Asmaa A and Elfeky, Faten A and Omar, Nahed R and Aboushousha, Tarek and El-Wakil, Eman S},
  title = {Investigating Therapeutic Potential of Beta‐Glucan on Experimental Toxoplasmosis in Immunocompetent and Immunocompromised Mice: In Silico and in Vivo Studies},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202500370}
}
Kostenlos starten →